Julie L. Gerberding (MCK)

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

MRK
Merck & Co.
EVP, Chief Patient Officer
2016 or earlier – last filing Feb 2022

People who currently share a board or management team with this person.

Purchases and sales reported on Form 4 at S&P 500 companies.

Date	Company	Type	Shares	Price	Value
Nov 1, 2021	MRKMerck & Co.	Sale	96,270	$87.91	$8.5M
Jul 17, 2020	MRKMerck & Co.	Sale	18,174	$80.01	$1.5M
Jul 17, 2020	MRKMerck & Co.	Sale	18,111	$80.00	$1.4M
Jan 13, 2020	MRKMerck & Co.	Sale	102,073	$89.34	$9.1M
Nov 7, 2018	MRKMerck & Co.	Sale	36,218	$75.14	$2.7M
May 15, 2018	MRKMerck & Co.	Sale	9,972	$59.66	$595K
Nov 7, 2016	MRKMerck & Co.	Sale	85,523	$60.02	$5.1M

SEC reporting-owner ID (CIK) 1628884 · all filings on EDGAR